Next Generation Sequencing (NGS) Market Size, Share, and Growth 2024-2031
Next Generation Sequencing (NGS) Market: Size and Share
-
CAGR (2023 - 2031)16.8% -
Market Size 2023
US$ 10.00 Billion -
Market Size 2031
US$ 34.75 Billion
Market Dynamics
- Advancements in Next-Generation Sequencing (NGS) to Favor Market
- Strategic Developments By Companies
- New Guidance Launched by WHO On The Use Of Targeted Next-Generation Sequencing
- Increased Throughput and Reduced Costs
Market Segmentation
- Platforms
- Services
- Consumables
- Genome Sequencing
- Exome Sequencing
- Resequencing & Targeted Sequencing
- Diagnostics
- Drug Discovery
- Precision Medicine
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Hospitals & Clinics
Next Generation Sequencing (NGS) Market Players Density: Understanding Its Impact on Business Dynamics
The Next Generation Sequencing (NGS) Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Next Generation Sequencing (NGS) Market are:
- Illumina, Inc.
- Thermo Fisher Scientific, Inc.
- Qiagen N.V.
- Beijing Genomics Institute
- Perkinelmer, Inc.
- F. Hoffmann-La Roche AG
Disclaimer: The companies listed above are not ranked in any particular order.
- Get the Next Generation Sequencing (NGS) Market top key players overview